Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Value
Increase
Decrease
Funds Holding
4,841
Funds Holding Change
+492
Funds Holding Growth
+11%
Value
$1.5T
Holding in Top 10
1,103
Top 10 Change
+137
Top 10 Growth
+14%
Value Growth
+8%
New
683
Increased
2,151
Reduced
1,791
Closed
117
Capital Inflow
$59.1B
Capital Outflow
$36.2B
Net Capital Flow
+$22.9B
Capital Flow Change
+$72.9M
Calls
$27.2B
Puts
$23.1B
Net Calls
+$4.06B
Put/Call Ratio
0.85